Law360, New York (January 26, 2012, 5:36 PM ET) -- Gene sequencing company Illumina Inc. moved quickly Thursday to stymie a $5.7 billion hostile takeover bid by Swiss drugmaker Roche Holding Ltd., adopting a poison pill plan just one day after the offer was made.
Illumina had said it would review Roche’s offer on Wednesday to buy Illumina for $44.50 per share and was advising stockholders to take no action until it made a recommendation. But in adopting a poison pill plan Thursday, Illumina said it wanted to “deter coercive or otherwise unfair takeover tactics.”
Illumina adopted...
Illumina Rebuffs $5.7B Roche Bid With Poison Pill
To view the full article, take a free trial now.
